In mouse models immune cell manipulation plus chemotherapy achieves prostate cancer remission where chemotherapy alone fails
Blocking or removing immune-suppressing cells , researchers at the University of California, San Diego School of Medicine have found, allows a special type of chemotherapy — and the immune cells it activates — to destroy prostate tumors.
This combination therapy, termed chemoimmunotherapy, achieved near complete remission in mouse models of advanced prostate cancer. ...continue reading Targeting B Cells to Tackle Immune System Suppression in High Risk Prostate Cancers